Recently cleared by the FDA, the iQ3 point-of-care ultrasound system reportedly offers new advances in 3D imaging capabilities.
Offering a combination of enhanced image processing, artificial intelligence (AI) tools and improved 3D imaging, the Butterfly Network has unveiled the iQ3TM handheld ultrasound.
In addition to a “no focus” rubber lens that facilitates improved observation of small anatomical structures, the iQ3 point-of-care device also features 3D imaging advances with iQ Slice and iQ Fan.
Butterfly Network said the iQ Slice technology features automated steering of the beam for optimal organ scanning and can capture 46 ultrasound slices simultaneously across a wide angle. With real-time virtual fanning, the iQ Fan provides clinicians with smoother visualization of A-lines and other lung conditions, according to Butterfly Network.
The company added that these 3D imaging advances with the iQ3 device are combined with existing AI tools, six imaging modes and over 20 anatomical presets in Butterfly Network ultrasound devices.
“The introduction of Butterfly iQ3 includes a focus on higher precision capabilities for cardiovascular point-of-care ultrasound applications to inform complex decisions,” noted Partho Sengupta, M.D., the chief of cardiology at Rutgers Robert Wood Johnson Medical School. “In my early experience, I found that the enhancements in visualization technology and artificial intelligence, as well as image quality will greatly assist health care professionals in our efforts to continually improve outcomes for our patients.”
Current Insights and Emerging Roles for Contrast-Enhanced Mammography
May 10th 2024In a recent lecture at the 2024 ARRS Annual Meeting, Jordana Phillips, MD, discussed the role of contrast-enhanced mammography in staging breast cancer, evaluating response to neoadjuvant chemotherapy and recalls from screening.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.
New AI-Powered Ultrasound Devices May Enhance Efficiency in Women's Imaging
April 19th 2024One of the features on the new Voluson Signature 20 and 18 ultrasound devices reportedly uses automated AI tools to facilitate a 40 percent reduction in the time it takes to perform second trimester exams.